<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00789646</url>
  </required_header>
  <id_info>
    <org_study_id>SI 271/2008</org_study_id>
    <nct_id>NCT00789646</nct_id>
  </id_info>
  <brief_title>Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients</brief_title>
  <official_title>Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due
      to subconjunctival antibiotic and antifungal injection.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Very slow in enrolling participants
  </why_stopped>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric rating scale</measure>
    <time_frame>immediately after injection</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>24 hours after injection</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Corneal Ulcer</condition>
  <arm_group>
    <arm_group_label>NSS/Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First injection: Normal saline Second injection: 2% Lidocaine without adrenaline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine/NSS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First injection: 2% Lidocaine without adrenaline Second injection: Normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lidocaine/NSS</intervention_name>
    <description>First injection: subconjunctival 2% lidocaine without adrenaline 0.4 ml. before antibiotic injection Second injection (24 hours later): subconjunctival NSS 0.4 ml. before antibiotic injection</description>
    <arm_group_label>Lidocaine/NSS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NSS/Lidocaine</intervention_name>
    <description>First injection: subconjunctival NSS 0.4 ml. before antibiotic injection Second injection (24 hours later): subconjunctival 2% lidocaine without adrenaline 0.4 ml. before antibiotic injection</description>
    <arm_group_label>NSS/Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in
             these following features.

               1. corneal epithelial defect with stromal infiltration

               2. reaction in anterior chamber

               3. positive for bacteria or fungus

          -  The patients have to receive subconjunctival antibiotic injection twice at least.

          -  The patients must be informed consent.

        Exclusion Criteria:

          -  The patients who have history of allergy of local anesthetics, antibiotics or
             antifungal drugs.

          -  The patients who administered NSAIDs or weak opioids within 24 hours prior to
             subconjunctival antibiotic/antifungal injection.

          -  Unable to cooperate with the treatment.

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 11, 2008</study_first_submitted>
  <study_first_submitted_qc>November 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2008</study_first_posted>
  <last_update_submitted>March 10, 2019</last_update_submitted>
  <last_update_submitted_qc>March 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Pramote Euasobhon</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>corneal ulcer</keyword>
  <keyword>painless</keyword>
  <keyword>subconjunctival injection</keyword>
  <keyword>antibiotics</keyword>
  <keyword>antifungal</keyword>
  <keyword>lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

